Skip to main content

Table 2 PCT and P-SEP values of present HD patient and previously reported HD patients without infection

From: A hemodialysis patient with Mycobacterium avium complex pericarditis in which remarkable presepsin elevation was not accompanied by procalcitonin elevation

NAssaySerum PCT, ng/mLRef.NAssayPlasma P-SEP, pg/mLRef.
123ECLIAmedian 0.231317CLEIAmedian (IQR) 1434 (1171–1891)19
89ECLIAmean ± SD 0.23 ± 0.25
median(range) 0.17 (9.05–1.73)
1410CLEIAmedian (IQR) 1305 (814–1858)20
20ELFAmean ± SD 0.50 ± 0.491520CLEIAmedian (IQR) 1510 (1205–1810)21
48ECLIAmedian (5th–95th percentile) 0.17 (0.090–0.824)1698CLEIAmean ± SD 1327 ± 91422
61ECLIAmean ± SD 0.20 ± 0.141713CLEIAmedian (IQR) 1160 (1070–1400)12
23IFAmedian (95% CI) 0.79 (0.45–0.99)18    
 CLEIA0.17–0.35  CLEIA19000–12100 (2019/1~2019/9) 
  1. PCT procalcitonin, P-SEP presepsin, HD hemodialysis, MAC Mycobacterium avium complex, ECLIA electrochemiluminescence immunoassay, ELFA enzyme-linked fluorescent assay, IFA immunofluorescence assay, SD standard deviation, CI confidence interval, IQR interquartile range
  2. The data of the last line indicate the PCT and P-SEP values in the present case report. All other values pertain to cases involving HD patients without infection